Oppenheimer & Co Inc’s Merck & Co Inc Position
Does Oppenheimer & Co Inc own Merck & Co Inc (MRK)? Yes — 184.2K shares worth $22M (+0.27% of its 13F portfolio) as of Q1 2026, up from 164.5K shares the prior filed quarter.
Position Value
$22M
Q1 2026
Shares
184.2K
% of Portfolio
+0.27%
Quarters Held
30
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 184.2K | $22M | +0.27% |
| Q4 2025 | 164.5K | $17M | +0.25% |
| Q3 2025 | 161.3K | $14M | +0.17% |
| Q2 2025 | 165.9K | $13M | +0.17% |
| Q1 2025 | 202.7K | $18M | +0.27% |
| Q4 2024 | 203.3K | $20M | +0.30% |
| Q3 2024 | 206.2K | $23M | +0.36% |
| Q2 2024 | 199.7K | $25M | +0.39% |
| Q1 2024 | 198.1K | $26M | +0.43% |
| Q4 2023 | 198.3K | $22M | +0.40% |
| Q3 2023 | 213.5K | $22M | +0.45% |
| Q2 2023 | 265.9K | $31M | +0.61% |
| Q1 2023 | 278.1K | $30M | +0.63% |
| Q4 2022 | 289.0K | $32M | +0.73% |
| Q3 2022 | 310.2K | $27M | +0.62% |
| Q2 2022 | 320.3K | $29M | +0.63% |
| Q1 2022 | 309.0K | $25M | +0.46% |
| Q4 2021 | 292.3K | $22M | +0.39% |
| Q3 2021 | 278.3K | $21M | +0.39% |
| Q2 2021 | 284.2K | $22M | +0.40% |
| Q1 2021 | 264.9K | $20M | +0.41% |
| Q4 2020 | 267.7K | $22M | +0.46% |
| Q3 2020 | 269.6K | $22M | +0.56% |
| Q2 2020 | 274.9K | $21M | +0.55% |
| Q1 2020 | 317.0K | $24M | +0.74% |
| Q4 2019 | 285.1K | $26M | +0.64% |
| Q3 2019 | 295.5K | $25M | +0.68% |
| Q2 2019 | 293.9K | $25M | +0.67% |
| Q1 2019 | 300.9K | $25M | +0.67% |
| Q4 2018 | 292.9K | $22M | +0.70% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of MRK.